Future perspectives on the treatment of gliomas must be focused on processes that induce ERSRs, apoptosis, autophagy, and paraptosis to achieve tumoral cell death with greater efficacy when using antitumor proteins like GRP78/BiP and CHOP in glioma. Here, HSPA5 is linked to central nervous system cancer.